Literature DB >> 19460673

Pooling of confounders did not induce residual confounding in influenza vaccination studies.

Rolf H H Groenwold1, Eelko Hak, Arno W Hoes.   

Abstract

PURPOSE: In observational studies on influenza vaccine effectiveness, confounding variables such as individual chronic diseases often are pooled before inclusion into a multivariable regression model. It has been suggested, however, that the pooling of confounders induces residual confounding, although empirical evidence is scarce. We set out to study the effects of combining several confounders into classes of co-morbidity.
METHODS: In a retrospective cohort study on the association between influenza vaccination and mortality, the effect of pooling of 20 individual diagnoses into three dichotomous co-morbidity variables indicating the presence of at least one of a range of diagnoses was studied. The sample size allowed for adjustments for 22 confounders (age, sex, and 20 individual cardiovascular, pulmonary, or oncologic diagnoses).
RESULTS: After adjustment for age and sex, further adjustment for 20 separate confounders or the three pooled co-morbidity variables resulted in comparable estimates of influenza vaccine effectiveness: odds ratio 0.78 (95% confidence interval, 0.62-0.98) and odds ratio 0.74 (95% confidence interval, 0.59-0.93), respectively.
CONCLUSION: We conclude that pooling of several (related) confounders in influenza vaccine effectiveness studies in health care databases is unlikely to induce important residual confounding.

Mesh:

Substances:

Year:  2009        PMID: 19460673     DOI: 10.1016/j.annepidem.2009.02.001

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  3 in total

1.  Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

Authors:  Danuta M Skowronski; Naveed Z Janjua; Gaston De Serres; Travis S Hottes; James A Dickinson; Natasha Crowcroft; Trijntje L Kwindt; Patrick Tang; Hugues Charest; Kevin Fonseca; Jonathan B Gubbay; Nathalie Bastien; Yan Li; Martin Petric
Journal:  BMJ       Date:  2011-02-03

2.  Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.

Authors:  James E Fielding; Kristina A Grant; Georgina Papadakis; Heath A Kelly
Journal:  BMC Infect Dis       Date:  2011-06-14       Impact factor: 3.090

Review 3.  Vaccines for preventing influenza in the elderly.

Authors:  Vittorio Demicheli; Tom Jefferson; Carlo Di Pietrantonj; Eliana Ferroni; Sarah Thorning; Roger E Thomas; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.